2931 - 2940 of 8673 Results
Title
Year
-
RESTRICTEDTitle: Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA MutationsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 106End Page: 118Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28818Citation Count: 25
-
OPENTitle: CoolMPS: evaluation of antibody labeling based massively parallel non-coding RNA sequencingJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 49Issue #: 2Start Page: e10End Page: e10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkaa1122Best OA location URL: https://doi.org/10.1093/nar/gkaa1122Citation Count: 14
-
OPENTitle: Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PDJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00476-2Best OA location URL: https://www.nature.com/articles/s41531-023-00476-2.pdfCitation Count: 14
-
RESTRICTEDTitle: Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse ModelJournal Name: Annals of NeurologyPublisher: WileyVol: 93Issue #: 5Start Page: 881End Page: 892Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.26600Citation Count: 5
-
OPENTitle: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 1SStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4201593Citation Count: 69
-
OPENTitle: Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 146Issue #: 1Start Page: 51End Page: 75Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-023-02585-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-023-02585-x.pdfCitation Count: 18
- Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease2021OPENTitle: Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00182-xBest OA location URL: https://www.nature.com/articles/s41531-021-00182-x.pdfCitation Count: 27
-
OPENTitle: Cortical structural involvement and cognitive dysfunction in early Parkinson's diseaseJournal Name: NMR in BiomedicinePublisher: WileyVol: 31Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/nbm.3900Best OA location URL: https://ora.ox.ac.uk/objects/uuid:2905d363-4eee-4049-a1ec-b9df071ca9c0/files/md1f990179dc1b0f396affef57468ccaaCitation Count: 8
-
OPENTitle: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 3Start Page: e16End Page: e16Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awx378Best OA location URL: https://academic.oup.com/brain/article-pdf/141/3/e16/25046297/awx378.pdfCitation Count: 8
-
OPENTitle: Treatment response to onabotulinumtoxinA in cervical dystonia patients with anterocollis and retrocollisJournal Name: ToxiconPublisher: Elsevier BVVol: 248Issue #:Start Page: 108035End Page: 108035Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.toxicon.2024.108035Best OA location URL: https://doi.org/10.1016/j.toxicon.2024.108035Citation Count: 2